Hollings Renton is of ANAPTYSBIO, INC. Currently has a direct ownership of 1,950 shares of ANAB, which is worth approximately $28,372. The most recent transaction as insider was on Nov 29, 2024, when has been sold 10,000 shares (Common Stock) at a price of $25.0 per share, resulting in proceeds of $250,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.95K
0% 3M change
n/a 12M change
Total Value Held $28,372

HOLLINGS RENTON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 29 2024
SELL
Open market or private sale
$250,000 $25.0 p/Share
10,000 Reduced 83.68%
1,950 Common Stock
Nov 29 2024
BUY
Exercise of conversion of derivative security
$69,300 $6.93 p/Share
10,000 Added 45.56%
11,950 Common Stock
Jul 15 2024
SELL
Open market or private sale
$307,400 $30.74 p/Share
10,000 Reduced 83.68%
1,950 Common Stock
Jul 15 2024
BUY
Exercise of conversion of derivative security
$69,300 $6.93 p/Share
10,000 Added 45.56%
11,950 Common Stock
Jun 18 2024
SELL
Open market or private sale
$45,162 $23.16 p/Share
1,950 Reduced 50.0%
1,950 Common Stock
Jun 15 2024
BUY
Exercise of conversion of derivative security
-
3,900 Added 50.0%
3,900 Common Stock

Also insider at

ZYME
Zymeworks Inc. Healthcare
ZYME
Zymeworks Inc.
HR

Hollings Renton

San Diego, CA

Track Institutional and Insider Activities on ANAB

Follow ANAPTYSBIO, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANAB shares.

Notify only if

Insider Trading

Get notified when an Anaptysbio, Inc insider buys or sells ANAB shares.

Notify only if

News

Receive news related to ANAPTYSBIO, INC

Track Activities on ANAB